💨 Abstract
Quest Diagnostics reported second-quarter net income of $282 million, or $2.47 per share, exceeding analysts’ forecasts. Adjusted earnings were $2.62 per share. Revenue reached $2.76 billion, also surpassing projections. The company anticipates full-year earnings between $9.63 to $9.83 per share and revenue between $10.8 billion to $10.92 billion.
Courtesy: WTOP Staff
Suggested
A major forest fire in Greece forces several villages to evacuate -
McLean-based Booz Allen triples its startup investments after spending $100M -
Thousands of Afghans in the US face deportation after court refuses to extend their protected status -
Pentagon tightens rules on getting medical waivers to join the military -
AstraZeneca chooses Virginia for its largest-ever R&D and manufacturing investment -
Chiefs press on with stadium negotiations on both sides of the Kansas-Missouri state line -
Florida signs $245 million in contracts for ‘Alligator Alcatraz.’ Here’s a look by the numbers -
World Tour Citi Open Results -
War in Gaza tests ties between Israel and traditional European allies -
US government employee banned from leaving China -